NASDAQ:OZEM Roundhill GLP-1 & Weight Loss ETF (OZEM) Price, Holdings, & News $25.59 -0.28 (-1.08%) As of 03/3/2025 03:53 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrends About Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OZEM alerts:Sign Up Key Stats Today's Range$25.48▼$26.0950-Day Range$23.22▼$25.9852-Week Range$23.21▼$29.21Volume15,485 shsAverage Volume14,580 shsMarket Capitalization$41.71 millionAssets Under Management$40.63 millionDividend Yield0.20%Net Expense Ratio0.59%Aggregate RatingModerate Buy ETF OverviewThe Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.Read More… Roundhill GLP-1 & Weight Loss ETF ExpensesTypeOZEMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.59%0.57%0.56%0.52%0.53%Other Expenses0.00%0.57%0.50%0.46%0.53%Total Expense0.59%0.72%0.72%0.67%0.71%Fee Waiver0.00%-0.72%-0.50%-0.32%-0.55%Net Expense0.59%0.60%0.62%0.60%0.60% Receive OZEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roundhill GLP-1 & Weight Loss ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address OZEM ETF News HeadlinesDrug compounders sue over weight loss drugs’ removal from FDA shortage listFebruary 25, 2025 | msn.comWeight-loss drugs aren’t just slimming waists. They’re shifting the economy.February 23, 2025 | washingtonpost.comNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.March 4, 2025 | Brownstone Research (Ad)FDA gives compounders short reprieve as Novo Nordisk GLP-1 supply normalizesFebruary 21, 2025 | seekingalpha.comYearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA saysFebruary 21, 2025 | msn.comWeight-Loss Drugs Like Ozempic Can Help Alcohol AddictionFebruary 13, 2025 | msn.comSee More Headlines OZEM ETF - Frequently Asked Questions How have OZEM shares performed this year? Roundhill GLP-1 & Weight Loss ETF's stock was trading at $24.36 at the beginning of the year. Since then, OZEM shares have increased by 5.0% and is now trading at $25.59. View the best growth stocks for 2025 here. Who are Roundhill GLP-1 & Weight Loss ETF's major shareholders? Top institutional shareholders of Roundhill GLP-1 & Weight Loss ETF include National Bank of Canada FI (4.11%), Jane Street Group LLC (3.99%), OLD Mission Capital LLC (2.39%) and Cox Capital Mgt LLC (2.35%). How do I buy shares of Roundhill GLP-1 & Weight Loss ETF? Shares of OZEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Roundhill GLP-1 & Weight Loss ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Roundhill GLP-1 & Weight Loss ETF investors own include NVIDIA (NVDA), ARM (ARM), Berkshire Hathaway (BRK.B), Chipotle Mexican Grill (CMG), Coinbase Global (COIN), Femasys (FEMY) and Super Micro Computer (SMCI). Fund Details IssuerRoundhill Investments Fund NameRoundhill GLP-1 & Weight Loss ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:OZEM Inception Date5/21/2024 Fund ManagerWill Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous SymbolNASDAQ:OZEM WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings30 Fund Statistics Assets Under Management$40.63 million Average Daily Volume$0.00 Discount/Premium-0.14% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRoundhill Financial Inc. CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest1,400 shs Miscellaneous Outstanding Shares1,630,000BetaN/A 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report Top 10 OZEM HoldingsEli Lilly and Company (NYSE:LLY)Holding Weight: 17.35%Novo Nordisk A/S (NYSE:NVO)Holding Weight: 15.18%Roche Holding AGHolding Weight: 5.86%Chugai Pharmaceutical Co., Ltd.Holding Weight: 4.80%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.79%Zealand Pharma A/SHolding Weight: 4.40%Amgen (NASDAQ:AMGN)Holding Weight: 4.34%Innovent Biologics, Inc.Holding Weight: 3.93%Pfizer (NYSE:PFE)Holding Weight: 3.57%Hanmi Pharm. Co., Ltd.Holding Weight: 3.11%Full Holdings DetailsOZEM Sector ExposureOZEM Industry Exposure This page (NASDAQ:OZEM) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.